Novel Synthesis of Highly Functionalized 14-β-Hydroxysteroids Related to Batrachotoxin and Ouabain
作者:Stéphane Trudeau、Pierre Deslongchamps
DOI:10.1021/jo0355606
日期:2004.2.1
The use of anionic polycyclization was investigated in an effort to develop a versatile and convergent synthesis of advanced tetracyclic intermediates of batrachotoxin and ouabain analogues. Two new 5-(trialkylsilyl)-2-cyclohexenones as A ring precursors and a new Nazarov intermediate (D ring precursor) were prepared for this purpose. The reaction of the unsaturated β-keto aldehyde A ring precursor
On the stereochemical course of cuprate-mediated homoconjugate addition to an activated cyclopropane
作者:Douglass P. Taber、Kenneth H. Krewson、Krishna Raman、Arnold L. Rheingold
DOI:10.1016/s0040-4039(01)81584-7
日期:——
Cuprate-mediated homoconjugate addition to activated cyclopropane 6 is shown to proceed with inversion of absolute configuration at the apical carbon of the cyclopropane.
铜盐介导的均轭合物向活化的环丙烷6的添加显示出在环丙烷的顶碳处绝对构型的转化。
Process for producing 3-formylcyclopentanone derivatives
申请人:(Zaidanhojin) Sagami Chemical Research Center
公开号:US04073799A1
公开(公告)日:1978-02-14
A novel process for producing 3-formylcyclopentanone derivatives which are useful intermediates for syntheses of five-membered ring compounds such as prostaglandins is disclosed. In the process, 3-formylcyclopentanone derivatives are produced starting from .beta.-dicarbonyl compounds and azides through several-step reactions.
Stereochemistry of the nucleophilic ring-opening of activated bicyclo-[3.1.0]Hexanes.
作者:Daiei Tunemoto、Nobuhiko Araki、Kiyosi Kondo
DOI:10.1016/s0040-4039(01)92563-8
日期:1977.1
Identification of the Metabolic Profile of the α-Tubulin-Binding Natural Product (−)–Pironetin
作者:Sara K. Coulup、David S. Huang、Henry L. Wong、Gunda I. Georg
DOI:10.1021/acs.jmedchem.8b01774
日期:2019.2.14
Pironetin, the only crystallographically confirmed natural product to target a-tubulin, displays potent cytotoxic activity against sensitive and resistant A2780 ovarian cancer cell lines but is only marginally active in vivo. We now report that pironetin has a short half-life (<7 min) in human liver microsomes, suggesting that its limited in vivo efficacy is due to rapid metabolism. Further, we describe the discovery of epoxypironetin as pironetin's major metabolite in human liver microsomes.